{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Twist Bioscience Corporation"},"Symbol":{"label":"Symbol","value":"TWST"},"Address":{"label":"Address","value":"681 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 800 719-0671"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States."},"CompanyUrl":{"label":"Company Url","value":"https://www.twistbioscience.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Emily Marine Leproust","title":"Chairman & Chief Executive Officer"},{"name":"Patrick J. Finn","title":"President & Chief Operating Officer"},{"name":"Siyuan Chen","title":"Chief Technology Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}